. | Intervention group . | Control group . | Significance . |
---|---|---|---|
Number (male/female) | 61 (15/46) | 49 (15/34) | P = 0.841 |
Age (years) | 53.5 (12.4) | 53.5 (13.9) | P = 0.997 |
Ethnicity | |||
Non-Hispanic white | 22 | 20 | P = 0.930 |
Hispanic | 26 | 19 | |
Black | 8 | 7 | |
Other | 5 | 3 | |
A1C (%) | 9.6 ± 1.6 | 9.7 ± 1.8 | P = 0.638 |
Diabetes duration (years) | 7.3 ± 5.4 | 7.5 ± 8.3 | P = 0.921 |
Follow-up time (months) | 19.9 ± 8.4 | 24.0 ± 8.9 | P = 0.019* |
Dropouts (total) | 13 | 15 | P = 0.372 |
Withdraw/move | 6 | 3 | P = 0.384 |
Loss of benefit | 1 | 1 | |
Death | 1 | 0 | |
Loss to follow-up | 2 | 5 | |
No second photo | 3 | 6 |
. | Intervention group . | Control group . | Significance . |
---|---|---|---|
Number (male/female) | 61 (15/46) | 49 (15/34) | P = 0.841 |
Age (years) | 53.5 (12.4) | 53.5 (13.9) | P = 0.997 |
Ethnicity | |||
Non-Hispanic white | 22 | 20 | P = 0.930 |
Hispanic | 26 | 19 | |
Black | 8 | 7 | |
Other | 5 | 3 | |
A1C (%) | 9.6 ± 1.6 | 9.7 ± 1.8 | P = 0.638 |
Diabetes duration (years) | 7.3 ± 5.4 | 7.5 ± 8.3 | P = 0.921 |
Follow-up time (months) | 19.9 ± 8.4 | 24.0 ± 8.9 | P = 0.019* |
Dropouts (total) | 13 | 15 | P = 0.372 |
Withdraw/move | 6 | 3 | P = 0.384 |
Loss of benefit | 1 | 1 | |
Death | 1 | 0 | |
Loss to follow-up | 2 | 5 | |
No second photo | 3 | 6 |
Data are means ± SD, unless otherwise indicated.